Scorpius Holdings, Inc.
SCPX
Rank in Stocks
#34133
Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing,... Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. It is also involved in the provision of various process development services, including upstream and downstream development and optimization, and analytical method development solutions, as well as cell line development, testing, and characterization services. The company serves the biotechnology and biopharmaceutical industries. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in San Antonio, Texas.
Share Price
$0.001
Last synced: 2026-11-09
Market Cap
$61.14K
Change (1 day)
400.00%
Change (1 year)
-16.67%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Scorpius Holdings, Inc. (SCPX)
Category
Healthcare
Operating Margin for Scorpius Holdings, Inc. (SCPX)
Operating Margin as of November 2026 TTM: -419.24%
According to Scorpius Holdings, Inc.'s latest financial reports, its current operating margin (TTM) is -419.24%. At the end of 2024 the company had an operating margin of -538.21%.
Operating Margin history for Scorpius Holdings, Inc. from 2015 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -419.24% | -22.10% |
| 2024 | -538.21% | -10.43% |
| 2023 | -600.90% | -21.34% |
| 2022 | -763.90% | -54.43% |
| 2021 | -1,676.40% | 89.17% |
| 2020 | -886.18% | 39.31% |
| 2019 | -636.11% | 111.03% |
| 2018 | -301.43% | -65.08% |
| 2017 | -863.10% | -77.54% |
| 2016 | -3,842.41% | 0.00% |
| 2015 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.09% |
US
|
|
| -149.01% | -99.64% |
US
|
|
| 25.57% | -100.06% |
AU
|
|
| 31.23% | -100.07% |
BE
|
|
| 29.35% | -100.07% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Scorpius Holdings, Inc.'s operating margin
What is Scorpius Holdings, Inc.'s operating margin?
Scorpius Holdings, Inc.'s operating margin is -419.24%, as of Nov 2026.
What was Scorpius Holdings, Inc.'s operating margin in 2024?
In 2024, Scorpius Holdings, Inc.'s operating margin was -538.21%, compared with -600.90% in 2023.
How has Scorpius Holdings, Inc.'s operating margin changed since 2019?
From 2019 to 2024, Scorpius Holdings, Inc.'s operating margin was highest in 2024 (-538.21%) and lowest in 2021 (-1,676.40%).
How does Scorpius Holdings, Inc.'s operating margin compare with similar companies?
Scorpius Holdings, Inc.'s operating margin (-419.24%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.